Owners, management and financials
CVR: 15517085
Secondary names: SOLOCHEM A/S, PHARMACOSMOS PHARMACEUTICALS A/S, NEBO A/S
DKK 2,176,000,000
Revenue
Net result: DKK 714,000,000
PHARMACOSMOS HOLDING A/S (100%)
CVR · view owners
Tobias Sidelmann Christensen, Claes Christian Strøm
1 more in management
Board: Jacob Tolstrup (chair) and 4 members
CVR · view management
Active
Founded 1 October 1991
CVR · view overview
158 employees
CVR · 2018
Director registered: Claes Christian Strøm
CVR · 18/09/2025
View the full event history
PHARMACOSMOS A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1991. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker. The board consists of Jacob Tolstrup (chair), Lars Christensen, Lars Green and Martin Holst Lange. The company is owned by PHARMACOSMOS HOLDING A/S. The company has 158 employees (2018). In 2026, the company reported revenue of DKK 2,176,000,000 and a net result of DKK 714,000,000 compared with DKK 1,622,000,000 the year before. Equity in the 2026 report amounted to DKK 2,775,000,000.
Source: annual report 2026, Danish Business Authority
The financial health of PHARMACOSMOS A/S appears robust, with a significant increase in revenue and profit over the past five years. In 2026, the company reported revenue of 2.176 billion DKK and a profit of 714 million DKK, following a peak in 2025 with revenue of 2.623 billion DKK and a profit of 1.622 billion DKK. Despite a decline in revenue from 2025 to 2026, the overall trend shows strong growth from 876 million DKK in 2022 to over 2 billion DKK in 2026. The equity position has also improved significantly, reaching 2.775 billion DKK in 2026, indicating solid financial stability. However, the declining revenue trend in the most recent year raises concerns about future growth potential in a competitive pharmaceutical manufacturing industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive fabrikation og virksomhed i forbindelse hermed
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/05/2025 – 30/04/2026 | 2.2 mia. | 714 mio. | 4.5 mia. | 2.8 mia. | 286 | |
| 202501/05/2024 – 30/04/2025 | 2.6 mia. | 1.6 mia. | 4.7 mia. | 2.2 mia. | 240 | |
| 202401/05/2023 – 30/04/2024 | 1.6 mia. | 789.7 mio. | 2.7 mia. | 1.6 mia. | 208 | |
| 202301/05/2022 – 30/04/2023 | 1.1 mia. | 114.3 mio. | 1.8 mia. | 854.6 mio. | 191 | |
| 202201/05/2021 – 30/04/2022 | 876.8 mio. | 170 mio. | 1.6 mia. | 807.5 mio. | 468 | |
| 202101/05/2020 – 30/04/2021 | 782.2 mio. | -136 mio. | 1.5 mia. | 642.8 mio. | 352 | |
| 202001/05/2019 – 30/04/2020 | 609.1 mio. | 56.5 mio. | 1.3 mia. | 884 mio. | 258 | |
| 201901/05/2018 – 30/04/2019 | 573.1 mio. | 102.1 mio. | 1.3 mia. | 827 mio. | 236 | |
| 201801/05/2017 – 30/04/2018 | 542.2 mio. | 69.1 mio. | 1.2 mia. | 720.8 mio. | 208 | |
| 201701/05/2016 – 30/04/2017 | 511.6 mio. | 158.7 mio. | 966.8 mio. | 656.8 mio. | 172 | |
| 201601/05/2015 – 30/04/2016 | 448 mio. | 102.7 mio. | 790.7 mio. | 547.7 mio. | 111 | |
| 201501/05/2014 – 30/04/2015 | - | 81.1 mio. | 740.2 mio. | 496.9 mio. | 105 | |
| 201401/05/2013 – 30/04/2014 | - | 6.2 mio. | 629.8 mio. | 394.8 mio. | 105 | |
| 201301/05/2012 – 30/04/2013 | - | 115.5 mio. | 744.7 mio. | 435.3 mio. | 106 |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of PHARMACOSMOS A/S is 15517085.
PHARMACOSMOS A/S is owned by PHARMACOSMOS HOLDING A/S.
The management of PHARMACOSMOS A/S consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker.
The board of PHARMACOSMOS A/S consists of Jacob Tolstrup, Lars Christensen and Lars Green, with Jacob Tolstrup as chair.
In 2026, PHARMACOSMOS A/S reported revenue of DKK 2,176,000,000.
PHARMACOSMOS A/S had 158 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
PHARMACOSMOS A/S has published its annual report for 2026. Revenue came to DKK 2,176,000,000, and the net result was DKK 714,000,000.
PHARMACOSMOS A/S has won the tender "Amgros 2026 1.207.a" issued by Amgros I/S worth 248,923,125 DKK.
As of September 18, 2025, Claes Christian Strøm is registered as director of PHARMACOSMOS A/S.
PHARMACOSMOS A/S has published its annual report for 2025. Revenue came to DKK 2,623,000,000, and the net result was DKK 1,622,000,000.
PHARMACOSMOS A/S has published its annual report for 2024. Revenue came to DKK 1,613,141,000, and the net result was DKK 789,701,000.
As of June 27, 2024, Milena Jordanova Olsen has joined the board of directors of PHARMACOSMOS A/S.
As of June 27, 2024, Lars Green has joined the board of directors of PHARMACOSMOS A/S.
As of June 27, 2024, Tommy Pedersen has left the board of directors of PHARMACOSMOS A/S.
As of December 8, 2023, Henrik Parker is registered as director of PHARMACOSMOS A/S.
As of December 8, 2023, Robert Guglielmetti has stepped down as director of PHARMACOSMOS A/S.
As of August 15, 2023, Martin Holst Lange has joined the board of directors of PHARMACOSMOS A/S.
PHARMACOSMOS A/S has published its annual report for 2023. Revenue came to DKK 1,104,166,000, and the net result was DKK 114,274,000.
PHARMACOSMOS A/S has published its annual report for 2022. Revenue came to DKK 876,811,000, and the net result was DKK 170,038,000.
As of June 28, 2022, Tobias Sidelmann Christensen is registered as adm. dir. of PHARMACOSMOS A/S.
As of June 28, 2022, Lars Christensen has stepped down as adm. dir. of PHARMACOSMOS A/S.
PHARMACOSMOS A/S has published its annual report for 2021. Revenue came to DKK 782,207,000, and the net result was DKK -136,005,000.
PHARMACOSMOS A/S has published its annual report for 2020. Revenue came to DKK 609,062,000, and the net result was DKK 56,457,000.
PHARMACOSMOS A/S has published its annual report for 2019. Revenue came to DKK 573,077,000, and the net result was DKK 102,068,000.
As of February 8, 2019, Jacob Tolstrup has joined the board of directors of PHARMACOSMOS A/S.
As of February 8, 2019, Axel Kierkegaard has left the board of directors of PHARMACOSMOS A/S.
PHARMACOSMOS A/S has published its annual report for 2018. Revenue came to DKK 542,240,000, and the net result was DKK 69,125,000.
PHARMACOSMOS A/S has published its annual report for 2017. Revenue came to DKK 511,601,000, and the net result was DKK 158,715,000.
PHARMACOSMOS A/S has published its annual report for 2016. Revenue came to DKK 448,039,126, and the net result was DKK 102,693,508.
PHARMACOSMOS A/S has published its annual report for 2015. Gross profit came to DKK 208,821,719, and the net result was DKK 81,142,658.
PHARMACOSMOS A/S has published its annual report for 2014. Gross profit came to DKK 109,910,137, and the net result was DKK 6,168,543.
PHARMACOSMOS A/S has published its annual report for 2013. Gross profit came to DKK 257,989,535, and the net result was DKK 115,450,541.
As of April 13, 2011, Robert Guglielmetti is registered as director of PHARMACOSMOS A/S.
As of June 14, 2010, Robert Guglielmetti has stepped down as økonomidirektør of PHARMACOSMOS A/S.
As of May 19, 2010, Odd Inge Vaage-Nilsen has stepped down as director of PHARMACOSMOS A/S.
As of September 15, 2008, EY Godkendt Revisionspartnerselskab has been appointed auditor of PHARMACOSMOS A/S.
As of September 15, 2008, CJ Partnership I/S has stepped down as auditor of PHARMACOSMOS A/S.
As of February 1, 2006, Robert Guglielmetti is registered as økonomidirektør of PHARMACOSMOS A/S.
As of February 1, 2006, Lars Christensen is registered as adm. dir. of PHARMACOSMOS A/S.
As of February 1, 2006, Odd Inge Vaage-Nilsen is registered as director of PHARMACOSMOS A/S.
As of November 29, 2005, PHARMACOSMOS HOLDING A/S is registered as an owner of PHARMACOSMOS A/S with an ownership share of 100%.
As of November 21, 2003, CJ Partnership I/S has been appointed auditor of PHARMACOSMOS A/S.
As of November 21, 2003, MJAKP2 I/S has stepped down as auditor of PHARMACOSMOS A/S.
As of June 20, 2002, MJAKP2 I/S has been appointed auditor of PHARMACOSMOS A/S.
As of June 20, 2002, SKANDINAVISK INDUSTRI VEDLIGEHOLD ApS has stepped down as auditor of PHARMACOSMOS A/S.
As of April 23, 2002, Axel Kierkegaard has joined the board of directors of PHARMACOSMOS A/S.
As of April 23, 2002, Tommy Pedersen has joined the board of directors of PHARMACOSMOS A/S.
As of April 23, 2002, Annemarie Sidelmann has left the board of directors of PHARMACOSMOS A/S.
As of April 23, 2002, Lars Juul Peitersen has left the board of directors of PHARMACOSMOS A/S.
As of February 9, 1996, Henry Marinus Christensen has left the board of directors of PHARMACOSMOS A/S.
As of December 15, 1994, Henry Marinus Christensen has stepped down as director of PHARMACOSMOS A/S.
As of October 14, 1994, Torkil Christensen has left the board of directors of PHARMACOSMOS A/S.
As of February 3, 1992, Erik Tronborg Andersen has stepped down as auditor of PHARMACOSMOS A/S.
As of February 3, 1992, Ulf Svejgaard Poulsen has left the board of directors of PHARMACOSMOS A/S.
As of February 3, 1992, Susanne Saul Stakemann has left the board of directors of PHARMACOSMOS A/S.
As of February 3, 1992, Per Emil Hasselbalch Stakemann has left the board of directors of PHARMACOSMOS A/S.
As of February 3, 1992, Per Emil Hasselbalch Stakemann has stepped down as director of PHARMACOSMOS A/S.
As of October 1, 1991, Erik Tronborg Andersen has been appointed auditor of PHARMACOSMOS A/S.
As of October 1, 1991, SKANDINAVISK INDUSTRI VEDLIGEHOLD ApS has been appointed auditor of PHARMACOSMOS A/S.
As of October 1, 1991, Ulf Svejgaard Poulsen has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Susanne Saul Stakemann has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Per Emil Hasselbalch Stakemann has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Henry Marinus Christensen has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Torkil Christensen has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Lars Christensen has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Annemarie Sidelmann has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Lars Juul Peitersen has joined the board of directors of PHARMACOSMOS A/S.
As of October 1, 1991, Per Emil Hasselbalch Stakemann is registered as director of PHARMACOSMOS A/S.
As of October 1, 1991, Henry Marinus Christensen is registered as director of PHARMACOSMOS A/S.
PHARMACOSMOS A/S was founded on October 1, 1991.
